Q3 2022 Holdings
Filed 2022-11-14 | 70 holdings | $335.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $98.9M | 280,026 | 29.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $84.5M | 1,772,987 | 25.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $55.8M | 1,985,151 | 16.7% |
| Absci Corporation(ABSI) | COM | 00091E109 | $25.1M | 8,031,094 | 7.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $22.0M | 282,460 | 6.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $21.7M | 3,503,190 | 6.5% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $9.1M | 1,299,139 | 2.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $7.2M | 752,097 | 2.1% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $6.0M | 1,920,960 | 1.8% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $1.9M | 558,099 | 0.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $453.0K | 696,377 | 0.1% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $362.0K | 266,365 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $290.4K | 12,957,222 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $226.7K | 21,719,191 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $132.4K | 1,899,545 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $94.2K | 4,508,204 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $85.6K | 2,370,614 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $78.0K | 1,536,362 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $75.8K | 3,334,355 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $70.1K | 4,087,625 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $63.0K | 3,645,309 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $62.6K | 2,876,637 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $61.0K | 3,399,900 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $55.0K | 2,973,029 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $54.2K | 1,591,085 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $51.7K | 1,505,126 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $50.7K | 1,917,212 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $47.7K | 1,365,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $40.9K | 8,548,145 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $39.2K | 3,006,684 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $36.2K | 7,512,029 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $35.5K | 5,765,818 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $33.9K | 178,792 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $32.6K | 2,684,396 | 0.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $32.0K | 70,487 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $31.9K | 19,808,234 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $31.9K | 525,575 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $31.9K | 157,321 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $30.8K | 1,954,419 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $26.9K | 34,604,516 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $26.0K | 1,061,295 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $24.9K | 2,109,564 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $23.6K | 6,242,756 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $21.8K | 3,140,026 | 0.0% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $20.9K | 14,380,327 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $18.9K | 784,832 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $18.0K | 407,659 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $17.9K | 6,952,760 | 0.0% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $16.0K | 946,825 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $15.6K | 2,545,275 | 0.0% |